Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Crataeva nurvala leaves may help reduce anxiety and improve sleep.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Using a combination of AMD3100 and FK506 can speed up and improve wound healing in diabetic rats.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Different substances affect hair and skin cell growth in various ways.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

LTBP1 is a key regulator in diseases and a potential target for new treatments.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

The LEF-1 binding site enhances gene expression in hair follicles, with other proteins aiding specific regulation.

FLCN helps control iron levels in cells.

Truncated LTBP-1 disrupts TGF-β signaling, affecting hair growth.

Epiprofin suppresses parathyroid hormone gene activity, helping regulate calcium levels and could be a treatment target for hyperparathyroidism.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.